Posted on 3/25/19
Liquidia Technologies Closes Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., March 25, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of . . .
Posted on 3/21/19
Liquidia Technologies Prices Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., March 21, 2019 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of . . .
Posted on 3/19/19
New Study: Reusable Bronchoscopes Cost More Than Sterile Single-use Bronchoscopes
Study urges hospitals to consider obtaining sterile single-use bronchoscopes for routine procedures to improve hospital economy and patient safety. Bronchoscopes – one of the most commonly . . .
Posted on 3/14/19
PharmMD Changes Company Name to AdhereHealth
Reflects vision of better health through medication adherence by resolving social determinants through disruptive technologies, engagement services and home-delivered pharmacy PharmMD™, a leading healthcare technology company . . .
Posted on 3/14/19
Stevens & Wilkinson Reveals Plans for Three New State Veterans Nursing Homes
Facilities will be the first of their kind in South Carolina Stevens & Wilkinson (S&W), a full-service architecture, engineering and interior design firm, in conjunction with . . .
Posted on 3/12/19
Aeterna Zentaris Announces Strategic Review and Engagement of Financial Advisor
CHARLESTON, S.C., March 12, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) announced today that its board of directors has formed a special committee . . .
Posted on 3/7/19
Dova Reports Better-than-expected Earnings Under New CEO
Dova Pharmaceuticals Inc. reported fourth-quarter financial results that were better than expected, the first results under its new chief executive officer.The company saw a a net . . .
Posted on 3/5/19
Durham-based Precision BioSciences Files for $100M IPO
A biotechnology company based in the Research Triangle Park has filed to raise $100 million in an initial public offering, according to a filing with the . . .
Posted on 3/4/19
Henry Schein Completes Acquisition Of North American Rescue
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners
Posted on 2/28/19
Syneos Health Announces SEC Investigation, Stock Falls Over 20 Percent
Syneos Health Inc. stock dropped over 20 percent in after-hours trading after announcing Wednesday that the Securities and Exchange Commission has started an investigation into its . . .
Posted on 2/28/19
Dova Pharmaceuticals: Not Investible Despite The Approval
SummaryDova has one approved drug that isn’t selling too well.Its lead indication has problems with the trial, its patent protection isn’t long, and it isn’t really . . .
Posted on 2/18/19
Spine Pain Center Partners with Revitalize Health
CHARLESTON, S.C., Feb. 17, 2019 (GLOBE NEWSWIRE) -- Spine Pain Center has joined forces with Revitalize Health, a nationally recognized wellness program, to offer people in . . .
Posted on 2/7/19
MobileSmith Health, Isabel Healthcare Team-Up with Baptist Children’s Hospital
RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- MobileSmith Health (OTCBB: MOST), a leader in the digital health and mobile development sector that is reshaping traditional . . .
Posted on 2/6/19
Biocryst Receives $100M Loan from Midcap Financial Trust
Biocryst Pharmaceuticals Inc., a Durham-based company focused on rare disease drug development, announced it has received a $100 million loan from Midcap Financial Trust.This loan will . . .
Posted on 2/6/19
Chimerix Announces Management Transition
DURHAM, N.C., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M. Michelle . . .
Posted on 2/6/19
Shift Admin, LLC Awarded 2019 KLAS Category Leader in Physician Scheduling
Today, KLAS Research named Shift Admin the 2019 Category Leader for Scheduling: Physician in their annual "Best in KLAS" report, confirming Shift Admin's position as the . . .
Posted on 2/6/19
BioCryst Strengthens Cash Position With Flexible $100 Million Debt Facility
RESEARCH TRIANGLE PARK, N.C., Feb. 06, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) announced today that the company has entered into a $100 million secured . . .
Posted on 1/31/19
Novan Provides Business Update
MORRISVILLE, N.C., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN) today provided an update on several aspects of its business.Novan . . .
Posted on 1/25/19
UNC-Chapel Hill Researchers File Patent for Zika Virus Vaccine
Four researchers at UNC-Chapel Hill’s School of Medicine filed an application with the U.S. Patent and Trademark Office for a new Zika virus vaccine.Ralph Baric, professor . . .
Posted on 1/21/19
Novan Threatened With Delisting As Its Stock Price Continues To Decline
Novan, Inc., a late-stage pharmaceutical company, has been threatened with having its stock delisted by Nasdaq, according to a Securities and Exchange Commission filing on Friday.Earlier . . .
Posted on 1/3/19
GENFIT and LabCorp Sign a Licensing Agreement
LILLE, France & CAMBRIDGE, Mass. & BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company, and GENFIT (Euronext: GNFT), a biopharmaceutical company focused on discovering . . .
Posted on 1/2/19
Novan Announces Management Changes and Provides Business Update
MORRISVILLE, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. (NASDAQ: NOVN) today announced several leadership promotions and business updates. These changes further strengthen the alignment . . .
Posted on 12/18/18
UnitedHealthcare Growing its Medicare Advantage Care Provider Network
Duke Health and UnitedHealthcare have expanded their network relationship, giving approximately 15,000 North Carolinians enrolled in UnitedHealthcare Medicare Advantage plans access to Duke Health physicians and . . .
Posted on 12/9/18
Tenax Therapeutics Announces Pricing of $10 Million Underwritten Offering
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced the . . .
Posted on 12/9/18
Covance Xcellerate Wins Best Technological Development in Clinical Trials
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today announced that its Covance Drug Development (Covance) business was awarded Best Technological Development in . . .
Charlotte Raleigh
